Oncology News | pharmaphorum

News

ASCO 25: Can GLP-1 drugs reduce cancer risk?

A study has suggested the benefits of GLP-1 agonists could extend to a reduction in the risk of a slew of cancers associated with being overweight.

News

ASCO 25: Jazz, PharmaMar reveal SCLC survival data

Jazz and PharmaMar have revealed the overall survival data with their small-cell lung cancer drug Zepzelca, described as a 'milestone' in the disease.

News

ASCO 25: Roche places Itovebi marker in breast cancer

Roche's Itovebi has become the first PI3K inhibitor to extend survival in HR-positive, HER2-negative breast cancer with a PIK3CA mutation.

News

Mixed outcomes for pharma in big week for FDA adcomms

There was good news for Johnson & Johnson at this week's ODAC meetings, but not for Roche, UroGen, and Pfizer.

News

UK trumpets £1bn investment plan from BioNTech

BioNTech has said it will commit up to £1bn in investment in the UK over the next decade, in what has been described as a "template" for the sector.

News

Pfizer snaps up PD-1/VEGF drug from China's 3SBio

Pfizer has joined the ranks of those developing cancer drugs that target PD-1 and VEGF, penning a $6bn licensing deal with China's 3SBio.

ASCO 25: Can GLP-1 drugs reduce cancer risk?

ASCO 25: Jazz, PharmaMar reveal SCLC survival data

ASCO 25: Roche places Itovebi marker in breast cancer

Mixed outcomes for pharma in big week for FDA adcomms

UK trumpets £1bn investment plan from BioNTech

Pfizer snaps up PD-1/VEGF drug from China's 3SBio

US pharma tariffs of up to 100% finalised by Trump

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks